Erypharm
About:
EryPharm is a biotech company for the industrial culture of red blood cells from stem cells.
Website: http://erypharm.com/
Twitter/X: EryPharm
Top Investors: AGORANOV, Corely
Description:
EryPharm is a biotech business that produces red blood cells for industrial use from stem cells. They produce cultured red blood cells, creating blood transfusion products. Their product notably is for the treatment of blood disorders and cancer patients, who require multiple transfusions.
Total Funding Amount:
16.4M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2016-01-01
Founders:
Luc Douay
Number of Employees:
11-50
Last Funding Date:
2016-07-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai